fda bulk compounding list 503a ipamorelin PCAC votes against four nominated drug substances 12 Peptides Off FDA Category
12 Peptides Off FDA Category 2: April 22 (2026) The Peptide Catalog FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of CJC 1295 Ipamorelin: FDA Status, Compounding Ban & 2026 The biggest regulatory moment for peptides in 2026 happens this week. On July 23 and 24, the FDA's Pharmacy Compounding Advisory Committee meets to vote on whether BPC 157, TB 500, KPV, MOTS c, DSIP Industry Update: Interim 503A and 503B Bulks Lists New Revisions
Pay in 4 interest-free payments of $6.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



.png)